German cardiovascular care accounts for every sixth Euro:
This article was originally published in Clinica
The treatment of cardiovascular (CV) diseases in Germany cost the health service some Euros35.4bn ($43.6bn) in 2002, the latest figures from the federal department for statistics (destatis) reveal. This accounted for 15.8% of the total Euros223.6bn expenditure on healthcare. Euros8.1bn was spent on treating high blood pressure and Euros7.8bn on cerebrovascular conditions, including stroke (Euros2bn) and brain infarct (Euros2bn). The cost of treating ischaemic heart conditions, including angina pectoris and heart infarction, amounted to Euros7bn. The figures have been released following a restructuring of the healthcare cost calculation mechanism has allowed destatis for the first time to display costs according to illness and age.
You may also be interested in...
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.
Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.
The US FDA has proposed moving two categories of hepatitis C diagnostics to class II from class III because they pose relatively low risk.